Concepedia

Janet Hanwell

JH

5

Publications

190

Citations

5

H-Index

1996

Active since

Affiliations

Institute of Cancer Research(Current)

Janet Hanwell is an author at Institute of Cancer Research specializing in medicine, pharmacology, and radiation oncology.

Top concepts

Publications per year

1996–2016

5

Publications

5

Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors.

Stephen Clarke, Janet Hanwell, M. de Boer et al. · Journal of Clinical Oncology · 1996 · 74 citations

Phase I study of oral JM216 given twice daily

Philip Beale, Florence I. Raynaud, Janet Hanwell et al. · Cancer Chemotherapy and Pharmacology · 1998 · 37 citations

, , +3

Metabolism, excretion and pharmacokinetics of a single dose of [ 14 C]-raltitrexed in cancer patients

Philip Beale, Ian Judson, Janet Hanwell et al. · Cancer Chemotherapy and Pharmacology · 1998 · 34 citations

, , +9

A study of motivations and expectations of patients seen in phase 1 oncology clinics

Saoirse Dolly, Eleftheria Kalaitzaki, M. Puglisi et al. · Cancer · 2016 · 31 citations · Full text

Preliminary experience with the use of chemotherapy (CT) following treatment with olaparib, a poly(ADP-ribose) polymerase inhibitor (PARPi), in patients with <i>BRCA1/2</i>-deficient ovarian cancer (BDOC).

J. Ang, Tami Yap, P. Fong et al. · Journal of Clinical Oncology · 2010 · 14 citations

, , +16

Rows per page

1–5 of 5